SCHEMBL6536243

SCHEMBL6536243

O=C(NCC1CCN(C(=O)OCc2ccccc2)CC1)c1ccnc(CCO)c1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 15/20 0.58
CYP2D6 P10635 4/20 0.55
CYP2C9 P11712 4/20 0.55
TPSAB1 Q15661 2/20 0.54
TPSD1 Q9BZJ3 2/20 0.54
TPSG1 Q9NRR2 2/20 0.54
F2 P00734 1/20 0.54
PLG P00747 1/20 0.54
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
CYP3A4 P08684 3/20 0.54
NAPEPLD Q6IQ20 1/20 0.49
KDM4E B2RXH2 1/20 0.48
PKM P14618 1/20 0.48
FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5368733 0.93 GRIN2B (0.60) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL14438481 0.90 GRIN2B (0.62) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5370917 0.90 GRIN2B (0.59) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5364448 0.88 GRIN2B (0.57) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5370887 0.88 GRIN2B (0.57) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5365292 0.88 GRIN2B (0.61) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5367461 0.86 GRIN2B (0.61) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5369779 0.86 GRIN2B (0.61) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5365134 0.86 GRIN2B (0.61) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1
SCHEMBL5369615 0.86 GRIN2B (0.61) GRIN2BCYP2D6CYP2C9TPSAB1TPSD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399160-A4 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO INC (US) 2004-08-25 EP disclosed
EP-1399160-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES Merck & Co., Inc. (US) 2004-03-24 EP disclosed
WO-2002100352-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO., INC. (US) 2002-12-19 WO disclosed